Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × ceralasertib × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Neoplasm Metastasis 1 Extensive Stage Small Cell Lung Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Bile Duct Neoplasms 1

Interventions

pembrolizumab 35 Blood Specimen Collection 34 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 15 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Drug Therapy 11 Cisplatin 11 atezolizumab 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 10 Fluorouracil 9 Trastuzumab 8 Pemetrexed 8 Leucovorin 8 Cetuximab 8 pertuzumab 7 olaparib 7 Temozolomide 7 Oxaliplatin 7 Observation 7 Irinotecan 7 Interviews as Topic 7 Radiosurgery 6 Panitumumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡